The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. Delivers practical, business-oriented compliance advice; integrates compliance and ethics requirements into business processes; develops and delivers training, communications, and guidance tailored to employee roles, risk areas, and business needs; and conducts monitoring to evaluate adherence to policies, procedures, controls, partnering with senior Compliance and Legal leadership as appropriate.